122 related articles for article (PubMed ID: 3355613)
1. A little more information about aggravation of probucol-induced HDL-reduction by clofibrate.
Yokoyama S; Yamamoto A; Kurasawa T
Atherosclerosis; 1988 Mar; 70(1-2):179-81. PubMed ID: 3355613
[No Abstract] [Full Text] [Related]
2. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
Tomikawa M; Nakayasu T; Tawara K; Abiko Y
Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate.
Saku K; Zhang B; Jimi S; Bai H; Hirata K; Sasaki N; Liu R; Arakawa K
Eur J Clin Pharmacol; 1995; 48(3-4):209-15. PubMed ID: 7589043
[TBL] [Abstract][Full Text] [Related]
4. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
[TBL] [Abstract][Full Text] [Related]
5. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
[TBL] [Abstract][Full Text] [Related]
6. Severe hypoalphalipoproteinemia induced by a combination of probucol and clofibrate.
Davignon J; Nestruck AC; Alaupovic P; Bouthillier D
Adv Exp Med Biol; 1986; 201():111-25. PubMed ID: 3541510
[TBL] [Abstract][Full Text] [Related]
7. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
Heller F; Harvengt C
Eur J Clin Pharmacol; 1983; 25(1):57-63. PubMed ID: 6617725
[TBL] [Abstract][Full Text] [Related]
8. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
Artery; 1982; 10(2):88-94. PubMed ID: 7092581
[TBL] [Abstract][Full Text] [Related]
9. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
Cortese C; Marenah CB; Miller NE; Lewis B
Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of probucol. I].
Donatelli L
Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
[No Abstract] [Full Text] [Related]
11. Effects of probucol on lipoprotein protein kinetics.
Nestel PJ
Artery; 1982; 10(2):95-8. PubMed ID: 7092582
[TBL] [Abstract][Full Text] [Related]
12. Plasma carnitine and lipid-lowering drugs.
Nestruck AC; Pande SV; Davignon J
Atherosclerosis; 1985 Jun; 55(3):353-6. PubMed ID: 4015753
[TBL] [Abstract][Full Text] [Related]
13. Lowered HDL cholesterol and incidence of ischaemic heart disease.
Miettinen TA; Huttunen JK; Strandberg T; Naukkarinen V; Mattila S; Kumlin T
Lancet; 1981 Aug; 2(8244):478. PubMed ID: 6115240
[No Abstract] [Full Text] [Related]
14. Is it harmful to lower HDL levels?
Henahan J
JAMA; 1981 Nov; 246(20):2311, 2315. PubMed ID: 7299948
[No Abstract] [Full Text] [Related]
15. Long-term use of probucol in the multifactorial primary prevention of vascular disease.
Miettinen TA; Huttunen JK; Naukkarinen V; Strandberg T; Vanhanen H
Am J Cardiol; 1986 Jun; 57(16):49H-54H. PubMed ID: 2873740
[TBL] [Abstract][Full Text] [Related]
16. Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia.
Dachet C; Motta C; Neufcour D; Jacotot B
Adv Exp Med Biol; 1988; 243():179-84. PubMed ID: 3223415
[No Abstract] [Full Text] [Related]
17. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
Duncan CH; Best MM
Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
[No Abstract] [Full Text] [Related]
18. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
Jackson JM; Lee HA
Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
[TBL] [Abstract][Full Text] [Related]
19. Influence of clofibrate, bile-sequestering agents and probucol on high-density lipoprotein levels.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):28B-30B. PubMed ID: 6577781
[TBL] [Abstract][Full Text] [Related]
20. [The effects of probucol in man (author's transl)].
Leutenegger M
Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
